3 US Growth Stocks With At Least 10 percent Insider Ownership

LQDA Stock  USD 11.23  0.32  2.77%   
About 74% of Liquidia Technologies' investor base is looking to short. The analysis of overall sentiment of trading Liquidia Technologies stock suggests that many investors are alarmed at this time. The current market sentiment, together with Liquidia Technologies' historical and current headlines, can help investors time the market. In addition, many technical investors use Liquidia Technologies stock news signals to limit their universe of possible portfolio assets.
  
As geopolitical tensions rise, the U.S. stock market has experienced early declines, with major indices such as the Dow Jones Industrial Average and SP 500 slipping amid investor concerns. In this environment of uncertainty, stocks with substantial insider ownership can offer a unique perspective on potential growth opportunities, as insiders may have confidence in their companys long-term prospects despite short-term market fluctuations.

Read at simplywall.st
Simply Wall St News at Macroaxis
  

Liquidia Technologies Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Liquidia Technologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Liquidia Technologies Fundamental Analysis

We analyze Liquidia Technologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Liquidia Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Liquidia Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Target Price

Target Price Comparative Analysis

Liquidia Technologies is currently under evaluation in target price category among its peers.

Liquidia Technologies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Liquidia Technologies stock to make a market-neutral strategy. Peer analysis of Liquidia Technologies could also be used in its relative valuation, which is a method of valuing Liquidia Technologies by comparing valuation metrics with similar companies.

Peers

Liquidia Technologies Related Equities

LYRALyra Therapeutics   10.53   
0%
100.0%
AGENAgenus   9.06   
0%
86.0%
GOSSGossamer Bio   4.29   
0%
40.0%
ABOSAcumen Pharmaceuticals   3.52   
0%
33.0%
NRXPNRX Pharmaceuticals   3.05   
0%
28.0%
INZYInozyme Pharma   2.95   
0%
28.0%
LEGNLegend Biotech   2.95   
0%
28.0%
KRONKronos Bio   2.11   
0%
20.0%
KALVKalvista Pharmaceuticals   2.09   
0%
19.0%
TECHBio Techne   0.88   
0%
8.0%
AMLXAmylyx Pharmaceuticals   0.18   
0%
1.0%
MIRMMirum Pharmaceuticals   0.02   
1.0%
0%
UTHRUnited Therapeutics   0.1   
1.0%
0%
IMCRImmunocore Holdings   0.76   
7.0%
0%
TERNTerns Pharmaceuticals   1.44   
13.0%
0%
BMRNBiomarin Pharmaceutical   1.50   
14.0%
0%
GERNGeron   1.94   
18.0%
0%
LRMRLarimar Therapeutics   2.05   
19.0%
0%
NVCTNuvectis Pharma   2.38   
22.0%
0%
PCVXVaxcyte   2.90   
27.0%
0%
REPLReplimune   3.76   
35.0%
0%
XFORX4 Pharmaceuticals   5.13   
48.0%
0%

Complementary Tools for Liquidia Stock analysis

When running Liquidia Technologies' price analysis, check to measure Liquidia Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Liquidia Technologies is operating at the current time. Most of Liquidia Technologies' value examination focuses on studying past and present price action to predict the probability of Liquidia Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Liquidia Technologies' price. Additionally, you may evaluate how the addition of Liquidia Technologies to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments